Classifying human cancer by analysis of gene expression

Trends in Molecular Medicine

Volumn 9, Issue 1, 2003, Pages 5-10

  Hampton, Garret M ^a   Frierson Jr , Henry F ^b  

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER CLASSIFICATION; DNA MICROARRAY; EARLY DIAGNOSIS; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; REVIEW;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SOFTWARE; TREATMENT OUTCOME;

EID: 0037248479     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)00006-0     Document Type: Review

References (37)

1. Adams, M.D. et al. (1993) Rapid cDNA sequencing (expressed sequence tags) from a directionally cloned human infant brain eDNA library. Nat. Genet. 4, 373-380
2. Venter, J.C. et al. (2001) The sequence of the human genome. Science 291, 1304-1351
3. Lander, E.S. et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921
4. Duggan, D.J. et al. (1999) Expression profiling using cDNA microarrays. Nat. Genet. 21, 10-14
5. Hannon, G.J. (2002) RNA interference. Nature 418, 244-251
6. Clark, E.A. et al. (2000) Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535
7. Welsh, J.B. et al. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978
8. Kim, J.H. et al. (2002) Osteopontin as a potential diagnostic biomarker for ovarian cancer. J. Am. Med. Assoc. 287, 1671-1679
9. Sherlock, G. (2000) Analysis of large-scale gene expression data. Curr. Opin. Immunol. 12, 201-205
10. Quackenbush, J. (2001) Computational analysis of microarray data. Nat. Rev. Genet. 2, 418-427
11. Vapnik, V. (1998) Statistical Learning Theory, Wiley
12. Golub, T.R. et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537
13. Armstrong, S.A. et al. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30, 41-47
14. Kelly, L.M. et al. (2002) CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML). Cancer Cell 1, 421-432
15. Weisberg, E. et al. (2002) Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412. Cancer Cell 1, 433-443
16. Yeoh, E.J. et al. (2002) Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1, 133-143
17. Capdeville, R. et al. (2002) A rationally developed, targeted anticancer drug. Nat. Rev. Drug Discov. 1, 493-502
18. Ferrando, A.A. et al. (2002) Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75-87
19. Giordano, T.J. et al. (2001) Organ-specific molecular classification of primary lung, colon, and ovarian adenocarcinomas using gene expression profiles. Am. J. Pathol. 159, 1231-1238
20. Su, A.I. et al. (2001) Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res. 61, 7388-7393
21. Ramaswamy, S. et al. (2001) Multiclass cancer diagnosis using tumor gene expression signatures. Proc. Natl Acad. Sci. U.S.A. 98, 15149-15154
22. Yeang, C.H. et al. (2001) Molecular classification of multiple tumor types. Bioinformatics 17, S316-S322
23. Diamandis, E.P. et al. (2000) Human kallikrein 6 (zyme/protease M/neurosin): a new serum biomarker of ovarian carcinoma. Clin. Biochem. 33, 579-583
24. Alizadeh, A.A. et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511
25. Shipp, M.A. et al. (2002) Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8, 68-74
26. Rosenwald, A. et al. (2002) The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl. J. Med. 346, 1937-1947
27. Veer, L.J. and De Jong, D. (2002) The microarray way to tailored cancer treatment. Nat. Med. 8, 13-14
28. Bittner, M. et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540
29. Perou, C.M. et al. (2000) Molecular portraits of human breast tumours. Nature 406, 747-752
30. Sorlie, T. et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. U.S.A. 98, 10869-10874
31. Veer, L.J. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536
32. Bhattacharjee, A. et al. (2001) Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl Acad. Sci. U.S.A. 98, 13790-13795
33. Garber, M.E. et al. (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl Acad. Sci. U.S.A. 98, 13784-13789
34. Singh, D. et al. (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1, 203-209
35. Pomeroy, S.L. et al. (2002) Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415, 436-442
36. Knight, J. (2001) Cancer comes under scrutiny in fresh genomics initiative. Nature 410, 855
37. Rhodes, D.R. et al. (2002) Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 62, 4427-4433